Coffee 'can cut risk of breast cancer tumours returning’
"A cancer-killing cocktail of the hormone drug tamoxifen and two coffees every day was found to reduce the risk of [breast cancer] tumours returning," the Mail Online reports. The same study also found evidence that caffeine slowed the cancer's growth.
Daily Mail (Source: Society for Endocrinology)
Source: Society for Endocrinology - April 23, 2015 Category: Endocrinology Source Type: news
Coffee could make breast cancer drug tamoxifen more effective
Conclusion
This study is interesting, but has several limitations. Its first finding was that women who report higher coffee consumption have smaller breast tumours, and also that their cancers are less likely to be ER positive. However, it seems that the women only reported their coffee consumption once, after diagnosis, and it is unclear from the write-up whether the questionnaire referred to their past or present coffee drinking habits. The women may also have under- or overestimated their coffee consumption, especially if they were asked to recall coffee consumption over a long period. The accuracy of coffee consumptio...
Source: NHS News Feed - April 22, 2015 Category: Consumer Health News Tags: Cancer Food/diet Source Type: news
Two cups of coffee a day can HALVE the risk of breast cancer returning
Caffeine in coffee causes cancer cells to grow more slowly and die more frequently, and can boost the effects of the drug tamoxifen, researchers from Lundt University and Bristol University found. (Source: the Mail online | Health)
Source: the Mail online | Health - April 21, 2015 Category: Consumer Health News Source Type: news
Coffee protects against breast cancer recurrence, detailed findings confirm
Coffee helps to protect against breast cancer, a number of research studies have shown. A new study is added to that research, confirming that coffee inhibits the growth of tumors and reduces the risk of recurrence in women who have been diagnosed with breast cancer and treated with the drug tamoxifen. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 21, 2015 Category: Science Source Type: news
More detailed findings confirm that coffee protects against breast cancer recurrence
(Lund University) A number of research studies have shown that coffee helps to protect against breast cancer. A new study led by Lund University, has confirmed that coffee inhibits the growth of tumors and reduces the risk of recurrence in women who have been diagnosed with breast cancer and treated with the drug tamoxifen. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 21, 2015 Category: Cancer & Oncology Source Type: news
New drug combination shows promise for breaking breast cancer resistance
A new combination of drugs has been developed that may overcome treatment resistance and relapse in breast cancer. While most women initially respond well to hormonal treatment with drugs such as tamoxifen, many go on to develop resistance and relapse. There is evidence that this is often due to activation of the Wnt signalling pathway, a gene involved in development which fuels the growth of the tumor. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 20, 2015 Category: Science Source Type: news
Sometimes, Diagnosis Is in the Eye of the Beholder
Rita Wilson's recent announcement of her experience with an early breast lesion emphasizes both the importance, and the limitations, of the pathologist in the evaluation of a breast biopsy. As laypeople, we assume that a pathologist can look at a piece of tissue and easily tell whether it is cancer or not. The truth is that there is some art as well as science in diagnosis.
To evaluate a biopsy, the tissue that is removed is cut up into small pieces and fixed in formalin to preserve it. It is then dehydrated and fixed in paraffin so that it can be sliced into slivers in a machine similar to the one used to slice ham. E...
Source: Healthy Living - The Huffington Post - April 15, 2015 Category: Consumer Health News Source Type: news
New Study on Tamoxifen Efficacy
Almost every day, I hear from friends and acquaintances that I have met through BFFL Co., and I feel very fortunate to be a trusted sounding board for their questions and concerns. Here's one email I received just a few days ago from a 40-year-old premenopausal woman who has completed chemo and lumpectomy/radiation for Stage 2 breast cancer:
"Hi Elizabeth, I was curious to know your thoughts regarding this study. I am currently on tamoxifen and will be undergoing a hysterectomy by the end of the year, as per my gynecological oncologist, because I'm at higher risk now not just for recurrence of breast cancer, but other can...
Source: Healthy Living - The Huffington Post - April 1, 2015 Category: Consumer Health News Source Type: news
This Vitamin Could Save Your Life
For years, I’ve recommended that my patients take a special family of super-nutrients with the power to boost their health and save their lives in at least a half a dozen ways.
I’m talking about tocotrienols, an especially potent form of vitamin E.
Tocotrienols, which comprise four out of the eight types of vitamin E, are powerful antioxidants that until recently were ignored by mainstream medicine.
But the patients at my wellness clinic and regular readers of my newsletter will know that I’ve recommended them as a critical nutrient for years.
And I do it because almost daily I observe the effects of the...
Source: Al Sears, MD Natural Remedies - March 26, 2015 Category: Complementary Medicine Authors: Dr. Al Sears Tags: Anti-Aging Nutrition antioxidants brain Cancer heart heart disease nutrients supplements vitamins Source Type: news
Tamoxifen Prevents Breast Cancer: Worth a Chat Tamoxifen Prevents Breast Cancer: Worth a Chat
Dr Lidia Schapira reports on the published findings of the IBIS-I study, which confirm that tamoxifen prevents breast cancer in patients at increased risk. Isn't it time to have a chat with patients? Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 23, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology Viewpoint Source Type: news
tamoxifen, Soltamox, Nolvadex (Discontinued)
Title: tamoxifen, Soltamox, Nolvadex (Discontinued)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 2/17/2015 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 17, 2015 Category: Cancer & Oncology Source Type: news
FDA approves new drug to treat estrogen-receptor–positive breast cancer
The U.S. Food and Drug Administration today approved a new drug to treat patients with advanced breast cancer, signaling a new strategy for arresting tumor growth and extending the time before cancer worsens in women with metastatic disease.
The drug, Ibrance (palbociclib), was studied in 165 post-menopausal women with advanced estrogen–receptor positive (ER+) and HER2–negative (HER2-) breast cancer who had received no prior systemic therapy for their metastatic disease. In 2013, after patients in a clinical study led by UCLA researchers showed a dramatic improvement, the FDA granted the drug “breakthrough therapy”...
Source: UCLA Newsroom: Health Sciences - February 3, 2015 Category: Universities & Medical Training Source Type: news
Should I Get the BRCA Test?
I remember when I first saw the acronym "BRCA" and wondered if it was a stock ticker symbol or perhaps the name of a new activist group. I quickly realized that it represented something much more relevant to me and to all women. BRCA stands for Breast ("BR") and Cancer ("CA") and refers to human genes (little bits of code within the body's cells) that help repair damage to our cells. When BRCA genes become mutated, or altered, to the point where they can no longer repair damage in other cells, then those cells with mistakes can ultimately become a cancerous growth. We need the protein that the BRCA genes code for in order ...
Source: Healthy Living - The Huffington Post - January 16, 2015 Category: Consumer Health News Source Type: news
Some 'Benign' Breast Masses Pose Greater Cancer Risk Than We Thought
By Gene Emery (Reuters Health) - A type of "benign" mass found in the breast tissue of about 100,000 U.S. women each year poses a greater risk of cancer than previously thought, according to a new review. The mass is classified as atypical hyperplasia, or atypia. Most women who have it - and one out of 10 women who have a breast biopsy do - are usually told that their test result was benign, even though their cells seemed to be exhibiting some early characteristics of a tumor. Doctors may tell those women that they face an above-average risk of cancer so they need to be ...
Source: Healthy Living - The Huffington Post - December 31, 2014 Category: Consumer Health News Source Type: news
Breast Cancer: Tamoxifen Benefit Durable (CME/CE)
(MedPage Today) -- Breast cancer prevention extends at least 20 years after 5-year course. (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - December 12, 2014 Category: OBGYN Source Type: news
